Literature DB >> 19883943

Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review.

Dag V Skjelstad1, Ulrik F Malt, Arne Holte.   

Abstract

BACKGROUND: Systematic studies addressing symptoms, signs and temporal aspects of initial bipolar prodrome are reviewed to identify potential clinical targets for early intervention.
METHODS: The databases PsycINFO, PubMed, EMBASE and British Nursing Index were searched for original studies.
RESULTS: Eight studies were identified. Irritability and aggressiveness, sleep disturbances, depression and mania symptoms/signs, hyperactivity, anxiety, and mood swings are clusters representing common symptoms and signs of the distal prodrome of bipolar disorder (BD). As time to full BD onset decreases, symptoms of mania and depression seem to increase gradually in strength and prevalence. The specificity of prodromal symptoms and signs appears to be low. Not every person who develops BD experiences a prolonged initial prodrome to the full illness. Current data on the mean duration of the prodrome are contradictory, ranging from 1.8 to 7.3 years. No qualitative studies were found. LIMITATIONS: Because of the scarcity of data, studies that did not explicitly investigate bipolar prodrome were included when thematically relevant. The selected studies are methodologically diverse and the validity of some findings is questionable. Findings must be interpreted cautiously.
CONCLUSIONS: The initial prodrome of BD is characterized by dysregulation of mood and energy. Because of the apparently low specificity of prodromal symptoms and signs of BD, it is currently neither possible nor advisable to predict the development of BD based solely on early phenomenology. More well-designed in-depth studies, including qualitative ones, are needed to characterize the initial bipolar prodrome. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19883943     DOI: 10.1016/j.jad.2009.10.003

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  47 in total

1.  Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.

Authors:  Robert K McNamara; Jeffrey R Strawn; Max J Tallman; Jeffrey A Welge; L Rodrigo Patino; Thomas J Blom; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-03-11       Impact factor: 2.576

Review 2.  The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents.

Authors:  Marta Hauser; Christoph U Correll
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

3.  A functional MRI study of working memory in adolescents and young adults at genetic risk for bipolar disorder: preliminary findings.

Authors:  Heidi W Thermenos; Nikos Makris; Susan Whitfield-Gabrieli; Ariel B Brown; Anthony J Giuliano; Erica H Lee; Stephen V Faraone; Ming T Tsuang; Larry J Seidman
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744

4.  First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Thomas J Blom; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Melissa P DelBello; Stephen M Strakowski
Journal:  Psychiatry Res       Date:  2015-10-09       Impact factor: 3.222

5.  Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Thomas J Blom; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Stephen M Strakowski; Melissa P DelBello
Journal:  Early Interv Psychiatry       Date:  2015-10-20       Impact factor: 2.732

6.  [Prevention of bipolar disorders].

Authors:  K Leopold; A Pfennig; E Severus; M Bauer
Journal:  Nervenarzt       Date:  2013-11       Impact factor: 1.214

7.  Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits.

Authors:  Robert K McNamara; Ann B Moser; Richard I Jones; Ronald Jandacek; L Rodrigo Patino; Jeffrey R Strawn; Stephen M Strakowski; Melissa P DelBello
Journal:  Psychiatry Res       Date:  2016-10-25       Impact factor: 3.222

8.  The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls.

Authors:  Christoph U Correll; Doreen M Olvet; Andrea M Auther; Marta Hauser; Taishiro Kishimoto; Ricardo E Carrión; Stephanie Snyder; Barbara A Cornblatt
Journal:  Bipolar Disord       Date:  2014-05-08       Impact factor: 6.744

9.  Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder.

Authors:  R Gonzalez; C Tamminga; M Tohen; T Suppes
Journal:  J Affect Disord       Date:  2013-03-11       Impact factor: 4.839

10.  Maternal T. gondii, offspring bipolar disorder and neurocognition.

Authors:  David Freedman; Yuanyuan Bao; Ling Shen; Catherine A Schaefer; Alan S Brown
Journal:  Psychiatry Res       Date:  2016-07-07       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.